Latest Corporate News News
Nvidia’s results cap a strong earnings season
Nvidia’s latest results helped close out a broadly positive first-quarter earnings season, with FactSet cited as showing 84% of S&P 500 companies beat earnings estimates and 81% beat revenue estimates. The report says blended S&P 500 earnings grew 28.4% year over year, with net profit margins reaching 14.8%, and argues Nvidia’s performance reinforces the AI rally.
AI infrastructure spending keeps accelerating
The same market wrap-up says Nvidia CEO Jensen Huang described AI factory buildout as the largest infrastructure expansion in human history, underscoring the scale of corporate AI investment. That commentary signals continued demand for chips, data-center hardware, and related services across the technology sector.
Samsung labor talks ease chip supply disruption fears
Navellier reports that Samsung and its largest labor union reached a tentative agreement after talks aimed at avoiding a strike amid a worsening memory-chip shortage. Any work stoppage at the world’s largest memory-chip maker would ripple through the global semiconductor supply chain, so the tentative deal is being watched closely.
Micron stands to benefit from tighter memory supply
The report says Micron Technology could gain if Samsung production is disrupted, as tighter memory supply can support pricing and demand for alternative vendors. This makes Micron one of the corporate beneficiaries of current semiconductor supply stress.
NextEra moves to expand with Dominion Energy deal
Navellier says NextEra Energy is buying Dominion Energy, tying the transaction to growing electricity demand from data centers in Virginia. The deal reflects how utility companies are positioning for higher power consumption from AI and cloud infrastructure.
Iran tensions ease after Trump signals a pause
The market wrap says President Trump posted that he would “hold off” on a planned military attack on Iran at the request of Gulf leaders to allow negotiations with Tehran. Traders appear to be responding to the possibility of de-escalation, which has helped support risk assets.
MaaT Pharma extends runway after regulatory setback
MaaT Pharma said it improved its cash visibility into November 2026 after taking cash-management measures, extending beyond August 2026. The company also said the EMA’s CHMP issued a negative-trend opinion on its marketing authorization application for MaaT013, and it plans to request re-examination once the formal opinion is issued.
IDEXX highlights investor-facing activity and conference presence
IDEXX Laboratories’ investor relations page shows recent company news and an upcoming appearance at the Stifel 2026 Jaws & Paws Conference. While not a major operational announcement, it is relevant corporate news for investors following the veterinary diagnostics company.